Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00027560 · OUTCOME

Extensive Chronic Graft-versus-Host Disease Unrelated and Mismatched Related Patients

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer · Source last updated 2013-01-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
up to 2 years post transplant

Analysis population: The number of unrelated and mismatched patients was analyzed as per protocol.

Groups in this outcome

Unrelated and Mismatched Related Patients

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Unrelated and Mismatched Related Patients25

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Unrelated and Mismatched Related Patients2Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    units
    Participants
groups
  1. id
    OG000
    title
    Unrelated and Mismatched Related Patients
param Type
NUMBER
population Description
The number of unrelated and mismatched patients was analyzed as per protocol.
reporting Status
POSTED
time Frame
up to 2 years post transplant
title
Extensive Chronic Graft-versus-Host Disease Unrelated and Mismatched Related Patients
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice